Join a Legacy of Innovation 125 Years and Counting!
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
We are currently seeking a GMA Oncology, Dato-DXd Intern for Summer 2025. This full-time position works for approximately 37.5 hours per week.
Responsibilities:Support with research projects on program strategy including research on competitive landscape, congress planning, and other ad hoc support of strategy team.
Education/Experience:
- Preferred experience in oncology
- Should be interested in medical affairs and skilled at scientific writing/communications
- Experience presenting data at congresses
Qualified candidates must currently be enrolled in an accredited PhD program with a concentration in biology, bioengineering, biochemistry or related field. Prior experience in a corporate business environment is preferred; experience in the pharmaceutical industry is a plus.
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
#J-18808-Ljbffr
